Reprogramming A.I in Gastrointestinal health

Connect with us
along with 50+ partners

All things WeOmics

What we do?

We are mapping the GI health system at unprecedented scale & granularity develop the next-generation of AI-powered analytics and digital solutions.

What we use?

WeOmics is Leveraging our technology platform and patient - derived Multimodal data to drive innovation in clinical research and precision medicine.

What we create?

WeOmics is building one of the the largest real - world evidence platform, starting with Gastro health. Combining a leading Gl health databases with Al - powered analytics and digital solutions, we are advancing the frontier of evidence generation and fueling innovation.

60M
Number of global colonoscopies annually
1.8M
New cases of colon cancer in 2018
$10B
IBD drug market
$34B
Endoscopic surgery market
Integrating with healthcare provider infrastructure systems to reinvent clinical trial recruitment. Our exclusive algorithms incorporate machine learning and advanced computer analysis to streamline the pre screening process for patient eligibility in clinical trials. By removing obstacles in recruitment, we expedite the introduction of novel drugs and therapies to the market.
To encompass all the multifaceted aspects of the disease from millions of clinical datapoints and datasets in Immune and oncological diseases, bringing Treatments to Market Faster with Real-World Evidence.
We use state-of-the-art machine learning techniques and medical data to pinpoint novel biomarkers associated with gastro health. We develop Al-driven medical technology to power and advance both the quality and continuity of patient care. By promoting standardized, high-quality diagnostic and prognostic tools
Integrating with healthcare provider infrastructure systems to reinvent clinical trial recruitment. Our exclusive algorithms incorporate machine learning and advanced computer analysis to streamline the pre screening process for patient eligibility in clinical trials. By removing obstacles in recruitment, we expedite the introduction of novel drugs and therapies to the market.
To encompass all the multifaceted aspects of the disease from millions of clinical datapoints and datasets in Immune and oncological diseases, bringing Treatments to Market Faster with Real-World Evidence.
We use state-of-the-art machine learning techniques and medical data to pinpoint novel biomarkers associated with gastro health. We develop Al-driven medical technology to power and advance both the quality and continuity of patient care. By promoting standardized, high-quality diagnostic and prognostic tools
1
2
00
01
02
03
Integrating with healthcare provider infrastructure systems to reinvent clinical trial recruitment. Our exclusive algorithms incorporate machine learning and advanced computer analysis to streamline the pre screening process for patient eligibility in clinical trials. By removing obstacles in recruitment, we expedite the introduction of novel drugs and therapies to the market.
To encompass all the multifaceted aspects of the disease from millions of clinical datapoints and datasets in Immune and oncological diseases, bringing Treatments to Market Faster with Real-World Evidence.
We use state-of-the-art machine learning techniques and medical data to pinpoint novel biomarkers associated with gastro health. We develop Al-driven medical technology to power and advance both the quality and continuity of patient care. By promoting standardized, high-quality diagnostic and prognostic tools
1
2
00
01
02
03

Partner with us

We have tens of strategic partnerships with academic
research institutions and biopharmaceutical and
medical device companies, working together to
accelerate R&D in gastro health.

Join us

Founding Story

A.I Made in Italy
First Spinout from Humanitas Hospital & Humanitas A.I Center
Work in Progress from June 2022
Create one of the World largest standardized structured clinical data & omics database
in the the gastro field to accelerate research
Goal to developing improve diagnosis and prognosis treatment paths in immunological and oncological diseases starting from the gastrointestinal field
Develop Clinical diagnostic and prognostic A.I algorithms in Gastro Intestinal diseases
First Case study in the field of Crohn's and IBD diagnostics and prognostics

Contact us

Please fill in the details below so
we can contact you.
First name
Last name
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

From A to Z, We've Got You Covered

But it's not just about the convenience of shopping from home. It's about the endless possibilities that online shopping offers. With a world of products at your fingertips, you can find exactly what you need and explore new products that you never knew existed.

Discover More